Metastatic Breast Cancer Progression Study

Open Research Studies
August 17, 2016

An LBBC industry partner is holding a focus group for people diagnosed with metastatic breast cancer that is either HER2-positive or HER2-negative and who have had a progression of their disease within the last 1-3 years.

The focus group will take place Thursday, September 22nd from 1:00 pm – 4:00 pm at the Loews Philadelphia Hotel. Transportation costs and overnight accommodation, if needed, will be covered. Food will be available.

A professional facilitator will lead participants through a series of questions about conversations between people in treatment and their healthcare providers at the point when a treatment change is needed. The goal is to gain insights on the patients perspectives on information, sensitivity, shared treatment decisions and caregiver’s involvement.

Participants will receive $112.50 for their participation in the focus group.  Apply today to see if you are eligible.

More In Metastatic

Insight Magazine March 2016
Article August 31, 2015
Additional Related Topics 
HER2-Positive